Sohrab Arora
Urology · Fort Worth, TXNPI 1033654769
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,185 of the $3,010 with a category attached, or 72.6%. 21 manufacturers reported payments, led by Procept Biorobotics Corporation at 35.5% of the total. 2025 is the largest year on record at $1,653, more than ten times the $106 reported in 2019. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 49 payments — averaging $61.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$1K
- EDAP Technomed Inc$384
- Boston Scientific$326
- Calyxo, Inc.$218
- Cook Medical LLC$167
- Palette Life Sciences, Inc.$151
- plus $696 from 15 others
Across 1 payment — averaging $20,618 each. An ownership or investment interest held by the physician or an immediate family member.
- Trinity Urology Solutions, LLC$21K
What the payments were for
- Travel & lodging$82527%
- Food & beverage$2,18573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 9 | $1,068 |
| EDAP Technomed Inc | 4 | $384 |
| Boston Scientific | 11 | $326 |
| Calyxo, Inc. | 2 | $218 |
| Cook Medical LLC | 4 | $167 |
| Palette Life Sciences, Inc. | 1 | $151 |
| Ferring Pharmaceuticals Inc. | 3 | $130 |
| Laborie Medical Technologies Corp. | 1 | $112 |
| Ambu Inc. | 1 | $93 |
| Agiliti Surgical, Inc. | 1 | $57 |
| Bluewind Medical | 1 | $46 |
| Conmed Corporation | 1 | $45 |
| Avation Medical, Inc. | 2 | $44 |
| Novartis | 1 | $34 |
| Telix Pharmaceuticals | 1 | $24 |
| Myovant Sciences Inc. | 1 | $21 |
| Coloplast | 1 | $20 |
| Urogen Pharma, Inc. | 1 | $20 |
| 180 Medical, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $16 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,010 in reported general payments places this provider in the 45th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 27 | $146 |
| Methocarbamol | 18 | $67 |
| Oxybutynin Chloride | 13 | $52 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $43 |
Paid to pharmacies, not to this prescriber.
Other urology in Fort Worth
- Adam HollanderFort Worth$53K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.